Table 3.
Silent period durations (SPs) and resting motor thresholds (RMTs) in iNPH patients and healthy controls
iNPH (n = 20) mean ± SD, range | Control (n = 20) mean ± SD, range | p-value | |
---|---|---|---|
Upper limb SP (ms) | 55.3 ± 17.7, 32.9–84.3 | 78.7 ± 16.1, 58.3–113.0 | < 0.001 |
Upper limb RMT (%-MSO) | 26.0 ± 4.4, 18.0–36.0 | 45.4 ± 12.2, 29.0–71.0 | < 0.001 |
(V/m) | 81.1 ± 13.0, 61.0–103.0 | 103.6 ± 23.6, 62.0–152.0 | 0.001 |
Lower limb RMT (%-MSO) | 41.5 ± 7.6, 27.0–60.0 | 59.2 ± 13.9, 37.0–84.0 | < 0.001 |
Significant differences are reported according to the Mann–Whitney U test for independent samples
MSO maximum stimulator output